@paulg I disagree. It's the lack of a market and overuse of regulation that creates the incentives for such an outcome. See Singapore.
-
-
- 9 more replies
New conversation -
-
-
@paulg How about a crowdfunding service for lowering trial costs? And why should only producers invest in trials, what about insurers etc?Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
@paulg incentives point the industry in the wrong direction, but I wouldn't compare them to Adam Smith's invisible hand.Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
@paulg Good analogy: payer, provider and patient have divergent interests and unequal control. Result: a costly punch for the patient.Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
@paulg nice summary of why high impact healthcare =/= consumer market anytime soon. Perhaps a policy binge is necessary to get wheels movingThanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.